FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis

Cell

Volumn 128, Issue 2, 2007, Pages 309-323

  Paik, Ji Hye ^a   Kollipara, Ramya ^a   Chu, Gerald ^a,b   Ji, Hongkai ^c   Xiao, Yonghong ^b   Ding, Zhihu ^a   Miao, Lili ^a,b   Tothova, Zuzana ^d   Horner, James W ^a   Carrasco, Daniel R ^a,b   Jiang, Shan ^a   Gilliland, D Gary ^d   Chin, Lynda ^a,b   Wong, Wing H ^e   Castrillon, Diego H ^a,f   DePinho, Ronald A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN SPROUTY2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO4; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER INHIBITION; CELL TYPE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE DELETION; GENETIC ANALYSIS; GERM LINE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYMOCYTE; VALIDATION PROCESS;

MAMMALIA;

EID: 33846295218     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.12.029     Document Type: Article

References (64)

1. Anderson M.J., Viars C.S., Czekay S., Cavenee W.K., and Arden K.C. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47 (1998) 187-199
2. Benezra R. Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc. Med. 11 (2001) 237-241
3. Biggs III W.H., Cavenee W.K., and Arden K.C. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12 (2001) 416-425
4. Bikfalvi A., Klein S., Pintucci G., and Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18 (1997) 26-45
5. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
6. Castrillon D.H., Miao L., Kollipara R., Horner J.W., and DePinho R.A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301 (2003) 215-218
7. Cook-Mills J.M. VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol. Immunol. 39 (2002) 499-508
8. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
9. Cully M., You H., Levine A.J., and Mak T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6 (2006) 184-192
10. Di Cristofano A., Pesce B., Cordon-Cardo C., and Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19 (1998) 348-355
11. Dijkers P.F., Medema R.H., Pals C., Banerji L., Thomas N.S., Lam E.W., Burgering B.M., Raaijmakers J.A., Lammers J.W., Koenderman L., et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol. 20 (2000) 9138-9148
12. Dong X.Y., Chen C., Sun X., Guo P., Vessella R.L., Wang R.X., Chung L.W., Zhou W., and Dong J.T. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 66 (2006) 6998-7006
13. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
14. Flores E.R., Tsai K.Y., Crowley D., Sengupta S., Yang A., McKeon F., and Jacks T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416 (2002) 560-564
15. Flores E.R., Sengupta S., Miller J.B., Newman J.J., Bronson R., Crowley D., Yang A., McKeon F., and Jacks T. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7 (2005) 363-373
16. Freeman D., Lesche R., Kertesz N., Wang S., Li G., Gao J., Groszer M., Martinez-Diaz H., Rozengurt N., Thomas G., et al. Genetic background controls tumor development in PTEN-deficient mice. Cancer Res. 66 (2006) 6492-6496
17. Furuyama T., Nakazawa T., Nakano I., and Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349 (2000) 629-634
18. Furuyama T., Kitayama K., Shimoda Y., Ogawa M., Sone K., Yoshida-Araki K., Hisatsune H., Nishikawa S., Nakayama K., Ikeda K., et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279 (2004) 34741-34749
19. Geisen C., Karsunky H., Yucel R., and Moroy T. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis. Oncogene 22 (2003) 1724-1729
20. Goumans M.J., Lebrin F., and Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc. Med. 13 (2003) 301-307
21. Gross I., Bassit B., Benezra M., and Licht J.D. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276 (2001) 46460-46468
22. Hacohen N., Kramer S., Sutherland D., Hiromi Y., and Krasnow M.A. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92 (1998) 253-263
23. Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8 (2005) 179-183
24. Hayashi M., Kim S.W., Imanaka-Yoshida K., Yoshida T., Abel E.D., Eliceiri B., Yang Y., Ulevitch R.J., and Lee J.D. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest. 113 (2004) 1138-1148
25. Heryanto B., and Rogers P.A. Regulation of endometrial endothelial cell proliferation by oestrogen and progesterone in the ovariectomized mouse. Reproduction 123 (2002) 107-113
26. Hosaka T., Biggs III W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., and Arden K.C. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101 (2004) 2975-2980
27. Inoki K., Li Y., Zhu T., Wu J., and Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 (2002) 648-657
28. Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 278 (2003) 35959-35967
29. Junger M.A., Rintelen F., Stocker H., Wasserman J.D., Vegh M., Radimerski T., Greenberg M.E., and Hafen E. The Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2 (2003) 20
30. Kang-Decker N., Tong C., Boussouar F., Baker D.J., Xu W., Leontovich A.A., Taylor W.R., Brindle P.K., and van Deursen J.M. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell 5 (2004) 177-189
31. Kato J., Tsuruda T., Kita T., Kitamura K., and Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2480-2487
32. Kramer S., Okabe M., Hacohen N., Krasnow M.A., and Hiromi Y. Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126 (1999) 2515-2525
33. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
34. Le Jan S., Amy C., Cazes A., Monnot C., Lamande N., Favier J., Philippe J., Sibony M., Gasc J.M., Corvol P., et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162 (2003) 1521-1528
35. Lee M.H., Williams B.O., Mulligan G., Mukai S., Bronson R.T., Dyson N., Harlow E., and Jacks T. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10 (1996) 1621-1632
36. Li G., Robinson G.W., Lesche R., Martinez-Diaz H., Jiang Z., Rozengurt N., Wagner K.U., Wu D.C., Lane T.F., Liu X., et al. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129 (2002) 4159-4170
37. Lin L., Hron J.D., and Peng S.L. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21 (2004) 203-213
38. Martins C.P., and Berns A. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis. EMBO J. 21 (2002) 3739-3748
39. Manning B.D., Logsdon N.M., Lipovsky A.I., Abbott D., Kwiatkowski D.J., and Cantley L.C. Feedback inhibition of Akt signalling limits the growth of tumors lacking Tsc2. Genes Dev. 19 (2005) 1773-1778
40. Medema R.H., Kops G.J., Bos J.L., and Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404 (2000) 782-787
41. Mouta Carreira C., Nasser S.M., di Tomaso E., Padera T.P., Boucher Y., Tomarev S.I., and Jain R.K. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61 (2001) 8079-8084
42. Neshat M.S., Mellinghoff I.K., Tran C., Stiles B., Thomas G., Petersen R., Frost P., Gibbons J.J., Wu H., and Sawyers C.L. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA 98 (2001) 10314-10319
43. Nikitenko L.L., Fox S.B., Kehoe S., Rees M.C., and Bicknell R. Adrenomedullin and tumour angiogenesis. Br. J. Cancer 94 (2006) 1-7
44. Podsypanina K., Ellenson L.H., Nemes A., Gu J., Tamura M., Yamada K.M., Cordon-Cardo C., Catoretti G., Fisher P.E., and Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96 (1999) 1563-1568
45. Potente M., Urbich C., Sasaki K.I., Hofmann W.K., Heeschen C., Aicher A., Kollipara R., Depinho R.A., Zeiher A.M., and Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115 (2005) 2382-2392
46. Puig O., Marr M.T., Ruhf M.L., and Tjian R. Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17 (2003) 2006-2020
47. Ramirez F., Pereira L., Zhang H., and Lee B. The fibrillin-Marfan syndrome connection. Bioessays 15 (1993) 589-594
48. Reich A., Sapir A., and Shilo B. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126 (1999) 4139-4147
49. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., and Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14 (2000) 3037-3050
50. Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., and Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 92 (1998) 3410-3415
51. Schneider A., Zhang Y., Guan Y., Davis L.S., and Breyer M.D. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am. J. Physiol. Renal Physiol. 284 (2003) F411-F417
52. Seoane J., Le H.V., Shen L., Anderson S.A., and Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 (2004) 211-223
53. Shim K., Minowada G., Coling D.E., and Martin G.R. Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing FGF signaling. Dev. Cell. 8 (2005) 553-564
54. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
55. Skurk C., Maatz H., Kim H.S., Yang J., Abid M.R., Aird W.C., and Walsh K. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem. 279 (2004) 1513-1525
56. Stahl M., Dijkers P.F., Kops G.J., Lens S.M., Coffer P.J., Burgering B.M., and Medema R.H. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168 (2002) 5024-5031
57. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523-534
58. Taketomi T., Yoshiga D., Taniguchi K., Kobayashi T., Nonami A., Kato R., Sasaki M., Sasaki A., Ishibashi H., Moriyama M., et al. Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nat. Neurosci. 8 (2005) 855-857
59. van der Heide L.P., Jacobs F.M., Burbach J.P., Hoekman M.M., and Smidt M.P. FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling. Biochem. J. 391 (2005) 623-629
60. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy-Burman P., Nelson P.S., et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4 (2003) 209-221
61. Wanner M., Celebi J.T., and Peacocke M. Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome. J. Am. Acad. Dermatol. 44 (2001) 183-187
62. Wingrove J.A., and O'Farrell P.H. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell 98 (1999) 105-114
63. Wu X., Alexander P.B., He Y., Kikkawa M., Vogel P.D., and McKnight S.L. Mammalian sprouty proteins assemble into large monodisperse particles having the properties of intracellular nanobatteries. Proc. Natl. Acad. Sci. USA 102 (2005) 14058-14062
64. You M.J., Castrillon D.H., Bastian B.C., O'Hagan R.C., Bosenberg M.W., Parsons R., Chin L., and DePinho R.A. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 1455-1460